{"AllianceGenome": "8976", "HGNC": "8976", "MIM": "602925", "_id": "5291", "_version": 1, "accession": {"genomic": ["AC020890.22", "AC067728.25", "AC117389.5", "AJ297549.1", "AJ297550.1", "AJ297551.1", "AJ297552.1", "AJ297553.1", "AJ297554.1", "AJ297555.1", "AJ297556.1", "AJ297557.1", "AJ297558.1", "AJ297559.1", "AJ297560.1", "AX327653.1", "CH471052.2", "CP068275.2", "NC_000003.12", "NC_060927.1"], "protein": ["AAB29081.1", "AAH03393.1", "AAH22049.1", "AAI14433.1", "BAG57175.1", "BAG64095.1", "CAC21449.1", "CAD20430.1", "CAH18210.1", "EAW79053.1", "EAW79054.1", "EAW79055.1", "EAW79056.1", "NP_001242974.1", "NP_006210.1", "P42338.1", "XP_006713722.1", "XP_011511197.1", "XP_016862108.1", "XP_047304263.1", "XP_047304264.1", "XP_047304265.1", "XP_047304266.1", "XP_047304267.1", "XP_047304268.1", "XP_047304269.1", "XP_047304270.1", "XP_047304271.1", "XP_054202824.1", "XP_054202825.1", "XP_054202826.1", "XP_054202827.1", "XP_054202828.1", "XP_054202829.1", "XP_054202830.1", "XP_054202831.1", "XP_054202832.1", "XP_054202833.1"], "rna": ["AI623206.1", "AK293754.1", "AK302937.1", "BC003393.1", "BC022049.2", "BC033948.2", "BC035432.2", "BC045790.1", "BC114432.1", "CR749357.1", "NM_001256045.2", "NM_006219.3", "S67334.1", "XM_006713659.4", "XM_011512895.3", "XM_017006619.2", "XM_047448307.1", "XM_047448308.1", "XM_047448309.1", "XM_047448310.1", "XM_047448311.1", "XM_047448312.1", "XM_047448313.1", "XM_047448314.1", "XM_047448315.1", "XM_054346849.1", "XM_054346850.1", "XM_054346851.1", "XM_054346852.1", "XM_054346853.1", "XM_054346854.1", "XM_054346855.1", "XM_054346856.1", "XM_054346857.1", "XM_054346858.1"], "translation": [{"protein": "XP_006713722.1", "rna": "XM_006713659.4"}, {"protein": "AAB29081.1", "rna": "S67334.1"}, {"protein": "XP_047304264.1", "rna": "XM_047448308.1"}, {"protein": "XP_054202833.1", "rna": "XM_054346858.1"}, {"protein": "XP_054202832.1", "rna": "XM_054346857.1"}, {"protein": "XP_047304271.1", "rna": "XM_047448315.1"}, {"protein": "NP_006210.1", "rna": "NM_006219.3"}, {"protein": "XP_054202825.1", "rna": "XM_054346850.1"}, {"protein": "XP_054202831.1", "rna": "XM_054346856.1"}, {"protein": "AAH22049.1", "rna": "BC022049.2"}, {"protein": "NP_001242974.1", "rna": "NM_001256045.2"}, {"protein": "XP_054202830.1", "rna": "XM_054346855.1"}, {"protein": "XP_047304263.1", "rna": "XM_047448307.1"}, {"protein": "AAI14433.1", "rna": "BC114432.1"}, {"protein": "AAH03393.1", "rna": "BC003393.1"}, {"protein": "XP_047304266.1", "rna": "XM_047448310.1"}, {"protein": "XP_047304267.1", "rna": "XM_047448311.1"}, {"protein": "BAG64095.1", "rna": "AK302937.1"}, {"protein": "XP_047304270.1", "rna": "XM_047448314.1"}, {"protein": "XP_054202827.1", "rna": "XM_054346852.1"}, {"protein": "XP_054202824.1", "rna": "XM_054346849.1"}, {"protein": "XP_047304268.1", "rna": "XM_047448312.1"}, {"protein": "XP_054202828.1", "rna": "XM_054346853.1"}, {"protein": "CAH18210.1", "rna": "CR749357.1"}, {"protein": "BAG57175.1", "rna": "AK293754.1"}, {"protein": "XP_054202826.1", "rna": "XM_054346851.1"}, {"protein": "XP_011511197.1", "rna": "XM_011512895.3"}, {"protein": "XP_047304269.1", "rna": "XM_047448313.1"}, {"protein": "XP_047304265.1", "rna": "XM_047448309.1"}, {"protein": "XP_054202829.1", "rna": "XM_054346854.1"}, {"protein": "XP_016862108.1", "rna": "XM_017006619.2"}]}, "alias": ["P110BETA", "PI3K", "PI3KBETA", "PIK3C1"], "ec": ["2.7.1.153", "2.7.11.1"], "ensembl": {"gene": "ENSG00000051382", "protein": ["ENSP00000289153", "ENSP00000417329", "ENSP00000417869", "ENSP00000418143", "ENSP00000418834", "ENSP00000419091", "ENSP00000419513", "ENSP00000419857", "ENSP00000420108", "ENSP00000438259", "ENSP00000501150"], "transcript": ["ENST00000289153", "ENST00000462294", "ENST00000462898", "ENST00000465581", "ENST00000469284", "ENST00000473435", "ENST00000477593", "ENST00000481749", "ENST00000483968", "ENST00000485060", "ENST00000487552", "ENST00000493568", "ENST00000544716", "ENST00000674063"], "translation": [{"protein": "ENSP00000501150", "rna": "ENST00000674063"}, {"protein": "ENSP00000418143", "rna": "ENST00000477593"}, {"protein": "ENSP00000419513", "rna": "ENST00000469284"}, {"protein": "ENSP00000420108", "rna": "ENST00000462898"}, {"protein": "ENSP00000417869", "rna": "ENST00000493568"}, {"protein": "ENSP00000419091", "rna": "ENST00000473435"}, {"protein": "ENSP00000418834", "rna": "ENST00000462294"}, {"protein": "ENSP00000419857", "rna": "ENST00000483968"}, {"protein": "ENSP00000417329", "rna": "ENST00000465581"}, {"protein": "ENSP00000289153", "rna": "ENST00000289153"}, {"protein": "ENSP00000438259", "rna": "ENST00000544716"}], "type_of_gene": "protein_coding"}, "entrezgene": "5291", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 47.7092394818, "exp_mis": 318.265319929, "exp_syn": 122.440014155, "lof_z": 6.26847174795247, "mis_z": 2.52964890397049, "mu_lof": 3.47976180493e-06, "mu_mis": 2.77962132849e-05, "mu_syn": 1.02070840511e-05, "n_lof": 4.0, "n_mis": 226.0, "n_syn": 130.0, "p_li": 0.999979002310697, "p_null": 1.45009533000363e-15, "p_rec": 2.09976893018265e-05, "syn_z": -0.423554774741197}, "bp": 3213, "cds_end": 138478185, "cds_start": 138374230, "n_exons": 22, "nonpsych": {"exp_lof": 42.7396846236, "exp_mis": 287.619053407, "exp_syn": 110.378250958, "lof_z": 6.12003566111528, "mis_z": 2.42741839999359, "mu_lof": 3.47976180493e-06, "mu_mis": 2.77962132849e-05, "mu_syn": 1.02070840511e-05, "n_lof": 2.0, "n_mis": 206.0, "n_syn": 117.0, "p_li": 0.999995654368985, "p_null": 9.3107002474876e-16, "p_rec": 4.34563101445532e-06, "syn_z": -0.39681778770132}, "nontcga": {"exp_lof": 43.8494401488, "exp_mis": 292.761053147, "exp_syn": 112.601759732, "lof_z": 5.9363770409883, "mis_z": 2.7883163678889, "mu_lof": 3.47976180493e-06, "mu_mis": 2.77962132849e-05, "mu_syn": 1.02070840511e-05, "n_lof": 4.0, "n_mis": 197.0, "n_syn": 120.0, "p_li": 0.999914616221283, "p_null": 4.4104324249447e-14, "p_rec": 8.53837786730758e-05, "syn_z": -0.441444065893594}, "transcript": "ENST00000477593.1"}, "exons": [{"cdsend": 138707275, "cdsstart": 138655388, "chr": "3", "position": [[138652697, 138655526], [138656141, 138656274], [138657689, 138657835], [138663905, 138664029], [138665035, 138665203], [138681966, 138682045], [138683677, 138683787], [138684624, 138684803], [138688874, 138688974], [138690999, 138691143], [138694785, 138694907], [138698906, 138699095], [138707158, 138707621]], "strand": -1, "transcript": "NM_001256045", "txend": 138707621, "txstart": 138652697}, {"cdsend": 138759343, "cdsstart": 138655388, "chr": "3", "position": [[138652697, 138655526], [138656141, 138656274], [138657689, 138657835], [138663905, 138664029], [138665035, 138665203], [138681966, 138682045], [138683677, 138683787], [138684624, 138684803], [138688874, 138688974], [138690999, 138691143], [138694785, 138694907], [138698906, 138699095], [138704442, 138704493], [138707158, 138707289], [138712207, 138712304], [138714467, 138714719], [138733360, 138733438], [138734633, 138734804], [138737706, 138737886], [138742557, 138742781], [138755753, 138755979], [138759172, 138759359], [138796462, 138796567], [138834694, 138834928]], "strand": -1, "transcript": "NM_006219", "txend": 138834928, "txstart": 138652697}], "exons_hg19": [{"cdsend": 138426117, "cdsstart": 138374230, "chr": "3", "position": [[138371539, 138374368], [138374983, 138375116], [138376531, 138376677], [138382747, 138382871], [138383877, 138384045], [138400808, 138400887], [138402519, 138402629], [138403466, 138403645], [138407716, 138407816], [138409841, 138409985], [138413627, 138413749], [138417748, 138417937], [138426000, 138426463]], "strand": -1, "transcript": "NM_001256045", "txend": 138426463, "txstart": 138371539}, {"cdsend": 138478185, "cdsstart": 138374230, "chr": "3", "position": [[138371539, 138374368], [138374983, 138375116], [138376531, 138376677], [138382747, 138382871], [138383877, 138384045], [138400808, 138400887], [138402519, 138402629], [138403466, 138403645], [138407716, 138407816], [138409841, 138409985], [138413627, 138413749], [138417748, 138417937], [138423284, 138423335], [138426000, 138426131], [138431049, 138431146], [138433309, 138433561], [138452202, 138452280], [138453475, 138453646], [138456548, 138456728], [138461399, 138461623], [138474595, 138474821], [138478014, 138478201], [138515304, 138515409], [138553536, 138553770]], "strand": -1, "transcript": "NM_006219", "txend": 138553770, "txstart": 138371539}], "generif": [{"pubmed": 2174051, "text": "This paper reports the first purification of a phosphoinositide 3-kinase and shows that the protein is a heterodimer of an 85 kd regulatory subunit that mediates binding to phosphorylated proteins and a 110 kd catalytic subunit."}, {"pubmed": 11752399, "text": "These results indicate that in addition to their roles in recruiting the catalytic subunit of PI3K to the insulin receptor substrate proteins, both p85alpha and p85beta play negative roles in insulin signaling"}, {"pubmed": 11916960, "text": "A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid."}, {"pubmed": 12502677, "text": "It is unlikely that the promoter polymorphisms -359T/C and -303A/G of the catalytic subunit p110beta gene of human PI 3-kinase have a major impact on insulin secretion, insulin sensitivity, or the risk of type 2 diabetes"}, {"pubmed": 12502677, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12507995, "text": "p110 has a role in activation of PI3K gamma along with G beta gamma"}, {"pubmed": 15242975, "text": "determinination of the involvement of PI3K and MAPK pathways and the importance of cross-talk between these pathways, in glucose-potentiated vascular smooth muscle cell chemotaxis to serum factors"}, {"pubmed": 15468162, "text": "Data highlight the differential signaling by p110alpha and -beta isoforms."}, {"pubmed": 15582274, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16091017, "text": "Introduction of a pH1 vector producing shRNA (short hairpin RNA) that targets p110beta abolished PIA [N6-(2-phenylisopropyl)adenosine]-induced Akt activation"}, {"pubmed": 16339315, "text": "although introduction of activating mutations from p110alpha at the corresponding sites in p110beta failed to render the enzyme oncogenic in human cells, the possibility remains that other mutations might activate the beta isoform"}, {"pubmed": 16380997, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16432180, "text": "p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase have roles in oncogenic transformation"}, {"pubmed": 17522703, "text": "Reduced activation of NF-kappaB via impaired PI3K/Akt activation under increased TNF-alpha levels could result in increased apoptosis of vitiliginous keratinocytes."}, {"pubmed": 17676480, "text": "bFGF augments hypoxia induced VEGF release in breast cancer cells mainly through the PI3K pathway and partly depending on HIF-1 activity."}, {"pubmed": 17977952, "text": "C allele is a causal variant capable of attenuating insulin resistance in obese children."}, {"pubmed": 17977952, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17986385, "text": "Our data indicate that different signalling pathways are involved in retinoic acid-induced up-regulation of the secretases."}, {"pubmed": 18285463, "text": "PI3Kalpha and -beta present distinct activation requirements and kinetics in G(1) phase, with a selective action of PI3Kalpha at the G(0)/G(1) phase transition"}, {"pubmed": 18327411, "text": "Phosphoinositide 3-kinase p110beta inhibitor TGX-221 inhibited shear-induced platelet activation and protected platelet function during extracorporeal circulation."}, {"pubmed": 18372911, "text": "p85alpha and p110beta are essential for androgen-stimulated AR transactivation, and their aberrant expression or activation might play an important role in prostate cancer progression"}, {"pubmed": 18398029, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18558630, "text": "required for sphingosine-1-phosphate -induced endothelial cell migration through activation of Rac1"}, {"pubmed": 18755892, "text": "Although p110alpha activation is required to sustain the proliferation of established PIK3CA-mutant tumors, PTEN-deficient tumors are dependent instead on p110beta signaling."}, {"pubmed": 18996102, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19097921, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19097921, "text": "Rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes."}, {"pubmed": 19380768, "text": "PI3K p110beta positively controls lipopolysaccharide-induced interleukin-12 production through the c-jun kinase (JNK)-1-dependent pathway in human macrophages and dendritic cells."}, {"pubmed": 19700402, "text": "PI3Kbeta plays an essential role in GPVI-mediated platelet aggregation and Akt activation"}, {"pubmed": 19815551, "text": "phosphoinositide 3-kinase isoforms alpha and beta have roles in glycoprotein VI-induced platelet signaling and thrombus formation"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20056178, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20058239, "text": "Our results support the concept that p110beta appears to be the predominant functional class I PI 3-kinase isoform in prostate cancer cells."}, {"pubmed": 20103642, "text": "Data show that similar responses were seen in cancer cells with wild-type or activated mutant PI3K genes treated with p110alpha/delta or p110alpha/beta/delta inhibitors in cell viability assays."}, {"pubmed": 20107106, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20107106, "text": "minor G allele of PIK3CB associates with decreased muscle subunit ratio and lower hepatic glucose production at high plasma insulin levels."}, {"pubmed": 20331378, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20508983, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20602615, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20691427, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21030680, "text": "This study shows that the enhanced transforming potential of p110beta is the result of its decreased inhibition by p85, due to the disruption of an inhibitory C2-iSH2 domain interface."}, {"pubmed": 21123564, "text": "In hyperglycemic leptin-deficient Lep(ob/ob) transgenic mice, leptin acutely and potently improves glucose metabolism, before any change of body fat mass, via a mechanism involving the p110alpha and -beta isoforms of phosphatidylinositol-3-kinase."}, {"pubmed": 21321382, "text": "Significance of this altered regulation in tumor models of PTEN deletion, as well as the potential implications of the unique p110beta regulation on GPCR-driven tumorigenesis."}, {"pubmed": 21362552, "text": "lipid kinase p110beta/p85beta elucidates an unusual SH2-domain-mediated inhibitory mechanism"}, {"pubmed": 21383062, "text": "study shows that p110beta nuclear localization signal and p85beta nuclear export sequence regulate p85beta/p110beta nuclear localization, supporting the idea that nuclear, but not cytoplasmic, p110beta controls cell survival"}, {"pubmed": 21487106, "text": "Results define PI3Kbeta as a potential therapeutic target in inflammatory disease."}, {"pubmed": 22528234, "text": "results suggested that down-regulation of p110beta expression by siRNA obviously reduced cell number via accumulation in G(0)-G(1) phase of the cell cycle."}, {"pubmed": 22701645, "text": "Combined blockade of P2Y12, P2Y1 and PI3-kinase p110beta fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation."}, {"pubmed": 22984590, "text": "Phosphoinositide 3-kinase C2beta regulates RhoA and the actin cytoskeleton through an interaction with Dbl"}, {"pubmed": 23051731, "text": "p110beta was activated near metaphase and controlled dynein/dynactin and Aurora B activities in kinetochores, chromosome segregation, and optimal function of the spindle checkpoint"}, {"pubmed": 23211529, "text": "Disrupting the p110beta-Gbetagamma interaction by mutation or with a cell-permeable peptide inhibitor blocked the transforming capacity of PI3Kbeta in fibroblasts and reduced the proliferation, chemotaxis, and invasiveness"}, {"pubmed": 23318440, "text": "Data indicate that phosphatidylinositol 3'-kinase (PI3K) alpha and beta p110 isoforms of PI3K are broadly expressed in myeloma."}, {"pubmed": 23434372, "text": "In mammalian cells, p110beta acts as a molecular sensor for growth factor availability and induces autophagy by activating a Rab5-mediated signaling cascade."}, {"pubmed": 23568272, "text": "p110alpha acts as a negative regulator of beta cell exocytosis and insulin secretion, while p110beta is a positive regulator of insulin secretion through a mechanism separate from its catalytic activity"}, {"pubmed": 23734178, "text": "Data sugget that the E633K mutant activates p110beta by enhancing its basal association with membranes."}, {"pubmed": 24114431, "text": "genetic association study in a population in Sweden: Data suggest that, among patients with growth hormone deficiency treated with hormone replacement therapy, homozygotes with SNP rs361072 in PIK3CB respond better than those with the major allele."}, {"pubmed": 24223153, "text": "HSP20 directly associates with PI3K subunits and suppresses its activity in hepatocellular carcinoma, resulting in the inhibition of the AKT pathway, and subsequently decreasing the growth of hepatocellular carcinoma."}, {"pubmed": 24284056, "text": "PI3Kbeta expression was elevated significantly in lung squamous cell carcinomas (SCC) compared with adenocarcinomas"}, {"pubmed": 24958106, "text": "Results show that cell stimulation promotes p110alpha and p110beta association, demonstrating oligomerization of PI3K catalytic subunits within cells."}, {"pubmed": 24995579, "text": "The score was higher in metastatic compared to primary lesions (P<0.001) and was significantly associated with potential measures of PI3K activation"}, {"pubmed": 25139353, "text": "Phosphoinositide 3-kinase beta mediates microvascular endothelial repair of thrombotic microangiopathy."}, {"pubmed": 25348717, "text": "PI3Kbeta regulates the nuclear envelope through upstream regulation of RCC1 and Ran"}, {"pubmed": 25398937, "text": "Platelet PI3Kbeta and GSK3 regulate thrombus stability at a high shear rate."}, {"pubmed": 25473181, "text": "PIK3CB is critically involved in response to preoperative radiotherapy and may serve as a novel target for therapeutic intervention."}, {"pubmed": 25550888, "text": "The expression of both PIK3CA and PIK3CB is increased and related to the development and progress of colorectal carcinoma and multidrug resistance"}, {"pubmed": 25605332, "text": "Overexpression of P110BETA accelerated differentiation in C2C12 cells and primary human myoblasts through an Akt-dependent mechanism, while expression of kinase-inactive P110BETA had the opposite effect."}, {"pubmed": 25982275, "text": "Our findings provide new insight into the genetic mechanisms underlying PI3K pathway activation in human tumors and indicate that PIK3Cb(D1067V) is a rational therapeutic target in certain cancers."}, {"pubmed": 26122654, "text": "TNFR1 Regulates Ovarian Cancer Cell Tumorigenicity Through PIK3CB-p110Beta"}, {"pubmed": 26206180, "text": "Collectively, these results highlight the cleavage of shp-1 as a critical event in reprogramming LPS pathway to promote both neutrophil recruitment and survival and provide a novel mechanistic framework for the investigation of the post-traumatic MODS."}, {"pubmed": 26318878, "text": "expression levels distinguish chronic lymphocytic leukemia B cells from normal B lymphocytes"}, {"pubmed": 26458524, "text": "miR-130a plays a critical role in attenuation of cardiac dysfunction and remodeling after myocardial infarction. The mechanisms involve activation of PI3K/Akt signaling via suppression of PTEN expression."}, {"pubmed": 26500061, "text": "Results indicate that p110alpha primarily mediates PI3K/AKT signaling in HER2+ PTEN deficient breast tumors whereas p110beta conditionally mediates HER2/PI3K signaling in the absence of p110alpha."}, {"pubmed": 26549638, "text": "our findings provide for the first time that PF-04691502 inhibits the constitutively activated PI3K/mTOR pathway in aggressive B-cell NHL cell lines associated with inhibition of cell cycle progression, cell proliferation and promotion of apoptosis."}, {"pubmed": 26590370, "text": "Cav-1 expression may be especially up-regulated in larger uveal melanomas. As it was correlated with PI3K expression and vasculogenic mimicry (VM) in this series of uveal melanoma, Cav-1 might induce the formation of VM via the PI3K-signalling cascade."}, {"pubmed": 26645485, "text": "inhibition of Rac or PI3K impedes adhesion of breast cancer cells and melanoma cells to the brain endothelium."}, {"pubmed": 26699864, "text": "The results of this study demomstrated that PI3 kinase mutations as novel prognostic markers in gliomas."}, {"pubmed": 26747178, "text": "PIK3CA and PIK3CB significantly increase multidrug resistance of CRC cells in vivo."}, {"pubmed": 26759240, "text": "PIK3CB D1067Y mutant behaved as an oncogene and transformed normal cells, an activity that was enhanced by PTEN depletion."}, {"pubmed": 26772887, "text": "Our study demonstrates that CSE/H2S system is regulated by miR-216a, and regulates ABCA1-mediated cholesterol efflux and cholesterol levels through the PI3K/AKT pathway."}, {"pubmed": 26773499, "text": "The data provide the first evidence that SJP protects SH-SY5Y cells against 6-OHDA toxicity possibly by inhibiting MAPK and NF-kappaB and activating PI3K/Akt signaling pathways."}, {"pubmed": 26775845, "text": "Our results demonstrated the pro-inflammatory and angiogenic effects of PlGF on HIMECs in IBD through activation of PI3K/Akt signaling pathway. PlGF/PI3K/Akt signaling may serve as a potential therapeutic target for IBD."}, {"pubmed": 26780727, "text": "Mefloquine acts on gastric cancer cells via suppressing PI3K/Akt/mTOR pathway."}, {"pubmed": 26792722, "text": "Our data suggested a potential role of Rab11-FIP2 in tumor progression and provided novel insights into the mechanism of how Rab11-FIP2 positively regulated cell migration and invasion in CRC cells."}, {"pubmed": 26884879, "text": "Combined detection of p110alpha and p110beta is helpful to determine the neoplastic potential of colorectal villous adenoma and serrated adenoma."}, {"pubmed": 26956052, "text": "High expression level of PIK3CB is associated with recurrence in glioblastoma."}, {"pubmed": 27013201, "text": "High PIK3CB expression is associated with breast Tumor Metastasis."}, {"pubmed": 27048245, "text": "Our study demonstrates that the IGF1R/p110b/AKT/mTOR axis confers resistance to BYL719 in PIK3CA mutant breast cancers."}, {"pubmed": 27169346, "text": "The protein kinase activity of PI3K phosphorylates serine residue 70 on Src to enhance its activity and induce EGFR transactivation following betaAR stimulation."}, {"pubmed": 27176780, "text": "PI3K isoforms p110a, p110b and p110g were selectively inhibited and effects on proliferation and migration assessed. Inhibition increased transcription of cancer stem cell genes in both models, suggesting de-differentiation in response to blockade of the PI3K/AKT/mTOR signalling axis."}, {"pubmed": 27184134, "text": "MYC gene copies, centromere status and PI3K activation may adversely impact trastuzumab treated metastatic breast cancer patient outcome and seem worthy validating in larger series."}, {"pubmed": 27190335, "text": "Single nucleotide polymorphism in the PIK3CB gene is associated with inflammation in chronic kidney disease."}, {"pubmed": 27356299, "text": "Cholesterol crystals activate specific cell signalling pathways which drive the production of inflammatory cytokines and degradative enzymes known to contribute to disease initiation and progression and are dependent on activation of Syk and PI3K"}, {"pubmed": 27422603, "text": "In conclusion, our data suggest that SIRPalpha signaling through SHP-2-PI3K-Akt2 strongly influences osteoblast differentiation from bone marrow stromal cells."}, {"pubmed": 27449010, "text": "In acute schizophrenia patients, the mRNA expression levels of DRD2 and PI3KCB were significantly lower than those in the healthy controls, while the AKT1 mRNA levels were significantly higher than those in the healthy controls."}, {"pubmed": 27481935, "text": "These findings highlight the importance of the hVps34-SGK3 pathway in counteracting inhibition of PI3K/Akt signalling."}, {"pubmed": 27806189, "text": "People with allelic variation in four genes related to cardiovascular diseases and metabolism were more likely to die: apolipoprotein (APO)C1 GG and AG carriers, APOE varepsilon4 carriers, insulin-degrading enzyme (IDE) TC carriers, and phosphatidylinositol 3-kinase (PI3KCB) GG carriers."}, {"pubmed": 27863432, "text": "PI3Kbeta associated with N-cadherin and PIK3CB depletion selectively disrupted N-cadherin cell adhesions in PTEN-mutant bladder carcinoma."}, {"pubmed": 27903677, "text": "Because apoptosis and tumor regression occurred early but not late in the treatment course, and proliferative arrest was maintained throughout treatment, p110a/b inhibitors may be considered short-term cytotoxic agents and long-term cytostatic agents"}, {"pubmed": 28002804, "text": "Results demonstrate that high levels of PIK3CB/p110beta associate with the early stages of endometrial tumorigenesis and increased cell proliferation, suggesting a proliferative advantage. These findings provide evidence that PIK3CB contributes to some of the pleiotropic functions of PI3K in endometrial cancer, particularly in cell proliferation."}, {"pubmed": 28122716, "text": "We demonstrated trophoblast cytoprotection by intervention with supraphysiological concentrations of relaxin, a process in part mediated through the PI3-kinase-Akt/PKB cell survival pathway. These results provide further rationale for clinical investigation of relaxin as a potential therapeutic in preeclampsia."}, {"pubmed": 28196852, "text": "Phosphatidylinositol-3-kinase signaling is regulated by INPP4B and PTEN in the triple-negative breast cancer cells."}, {"pubmed": 28302479, "text": "CONCLUSION: MiR-126 down-regulated S1PR2 and then prevented the activation of PI3K/AKT signaling pathway, which ultimately could damage intestinal mucosal barrier function."}, {"pubmed": 28339079, "text": "A combination of CAL-101, a p110delta-specific inhibitor, with bortezomib treatment of HT/EBV cells synergistically suppressed proliferation, reduced levels of drug resistance-related proteins, activated caspase cleavage and recovered expression of p110a/p110b."}, {"pubmed": 28442344, "text": "Likewise, inhibiting the PI3K-AKT-mTOR pathway with the ATP-competitive mTOR inhibitor PP242 reduced CD44 protein in SNU-423 and SNU-449 cells without altering CD44 mRNA levels."}, {"pubmed": 28549032, "text": "Expression of Phosphoinositide 3-Kinase p110alpha and p110beta Subunits and PIK3CA Mutation in Patients With Advanced Gastric Carcinoma."}, {"pubmed": 28578353, "text": "these data highlight a key role of the P2Y1/PI3Kbeta axis in endothelial cell proliferation downstream of ecto-F1-ATPase activation by apoA-I. Pharmacological targeting of this pathway could represent a promising approach to enhance vascular endothelial protection."}, {"pubmed": 28645941, "text": "GSK2636771 400 mg once daily orally induced sufficient exposure and target inhibition with a manageable safety profile. Genomic aberrations of PIK3CB may be associated with clinical benefit from GSK2636771"}, {"pubmed": 28712871, "text": "Taken together, these results suggested that the PI3K/Akt/FoxO pathway negatively regulates the BITC-induced antiproliferation in human colorectal cancer cells."}, {"pubmed": 28723560, "text": "Silencing CRKL expression in PTEN-null human cancer cells leads to a decrease in p110beta-dependent PI3K signaling and cell proliferation."}, {"pubmed": 28733463, "text": "TLR4 and C5aR crosstalk in dendritic cells induces a core regulatory network of RSK2, PI3Kbeta, SGK1, and FOXO transcription factors."}, {"pubmed": 28783168, "text": "We further demonstrate that loss of one allele of PTEN is sufficient to shift isoform dependency from p110alpha to p110beta in vivo. These results provide insight into the molecular mechanism by which ErbB2-positive breast cancer escapes p110alpha inhibition."}, {"pubmed": 28972046, "text": "This study identifies novel mechanistic biomarkers of PI3Kb inhibition in PTEN-null tumors supporting the concept that targeting PI3Kb may exploit a metabolic dependency that contributes to therapeutic benefit in inducing cell stress"}, {"pubmed": 29016844, "text": "High PIK3CB expression is associated with glioblastoma."}, {"pubmed": 29046393, "text": "data suggest that Rac1 can potentiate the activation of PI3Kbeta by GPCRs through an indirect mechanism, by driving the formation of macropinosomes that serve as signaling platforms for Gbetagamma coupling to PI3Kbeta."}, {"pubmed": 29203244, "text": "Taken together, our findings suggested that miR-126 alleviates ox-LDL-induced HUVECs injury through restoring autophagy flux via repressing PI3K/Akt/mTOR pathway, and further implicate the potential therapeutic targets to reverse atherosclerosis."}, {"pubmed": 29277178, "text": "PI3K p110beta Overexpression in Non-small Cell Lung Cancer"}, {"pubmed": 29902570, "text": "The crucial role of p110beta and the more subtle role of p110alpha in the production of PIP3 molecular species following platelet stimulation has been demonstrated."}, {"pubmed": 30243721, "text": "Data indicate that integrin subunit beta 1 (integrin beta1) knockdown sensitized drug-resistance (DR)-AsPC-1cells to gemcitabine in vitro and in vivo via blockade of Cdc42-p110beta-PI3K signaling."}, {"pubmed": 30496354, "text": "While the loss of endothelial PI3Kbeta activity produces cardioprotective effects, cardiac myocyte PI3Kbeta is protective against myocardial ischaemic injury."}, {"pubmed": 30499025, "text": "H2O2 induces oxidative stress to breast cancer tumor cell line MCF-7 in a dose dependent manner. Over-expression of p110beta protein restores pro-survival effects against H2O2 induced apoptosis and increases phosphorylated proto-oncogene proteins c-akt levels."}, {"pubmed": 30601996, "text": "The unusually complex regulation of PI3Kbeta by small and trimeric G proteins and receptor tyrosine kinases leads to a rich landscape of signaling responses at the cellular and organismic levels.[review]"}, {"pubmed": 30709367, "text": "miR-1287-5p was significantly downregulated in mammospheres and human breast cancer (BC) tissue compared to normal breast tissue and was associated with poor prognosis in BC patients. MiR-1287-5p significantly decreased cellular growth, cells in S phase of cell cycle, and tumor formation in vivo. PIK3CB was identified as a direct molecular interactor of miR-1287-5p and a novel prognostic factor in BC."}, {"pubmed": 30971294, "text": "Mechanistically, adenosine produced by CD73 binds to adenosine A2A receptor (A2AR) and activates Rap1, which recruits P110beta to the plasma membrane and triggers PIP3 production, thereby promoting AKT phosphorylation in HCC cells."}, {"pubmed": 31409694, "text": "macropinocytosis in response to receptor tyrosine kinase activation is strikingly dependent on a single class I PI3K isoform, namely PI3Kbeta (containing the p110beta catalytic subunit encoded by PIK3CB). Loss of PI3Kbeta expression or activity blocks macropinocytosis at early steps."}, {"pubmed": 31513749, "text": "Talc-sensitive cells have higher mRNA and protein expression of PI3K catalytic subunit beta. Both PI3Kalpha and -beta mediate talc-induced cell death and IL-6 secretion in lung carcinoma cells."}, {"pubmed": 31593688, "text": "DJ-1 may play a role in protecting RRPs from high glucose induced-oxidative injury. DJ-1 might improve mitochondrial function, inhibit ROS production and enhance antioxidant capacity to reduce apoptosis of retinal pericytes through the PI3K/AKT/mTOR signaling pathway which may be related to early pathogenesis of diabetic retinopathy."}, {"pubmed": 31601918, "text": "AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells."}, {"pubmed": 31629932, "text": "Expression of miR-337-3p is down-regulated in epithelial ovarian cancer (EOC) tissues and low expression of miR-337-3p is correlated with advanced pathological grade for patients. PIK3CA and PIK3CB were revealed to be direct targets of miR-337-3p. In vivo investigation confirmed that miR-337-3p is a tumor suppressor that control expression of PIK3CA and PIK3CB encoded protein: p110alpha and p110beta."}, {"pubmed": 32312789, "text": "N(6)-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression."}, {"pubmed": 32561752, "text": "YBX1 mediates autophagy by targeting p110beta and decreasing the sensitivity to cisplatin in NSCLC."}, {"pubmed": 32681423, "text": "FAK, paxillin, and PI3K in ameloblastoma and adenomatoid odontogenic tumor."}, {"pubmed": 32879446, "text": "Inactivation of endothelial cell phosphoinositide 3-kinase beta inhibits tumor angiogenesis and tumor growth."}, {"pubmed": 33128390, "text": "Hepatitis E viral infection regulates estrogen signaling pathways: Inhibition of the cAMPK-PKA-CREB and PI3K-AKT-mTOR signaling pathways."}, {"pubmed": 33526718, "text": "Distinct epithelial-to-mesenchymal transitions induced by PIK3CA (H1047R) and PIK3CB."}, {"pubmed": 33536247, "text": "Nuclear upregulation of class I phosphoinositide 3-kinase p110beta correlates with high 47S rRNA levels in cancer cells."}, {"pubmed": 33834259, "text": "SUMOylation modulates the stability and function of PI3K-p110beta."}, {"pubmed": 33852833, "text": "Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis."}, {"pubmed": 34023498, "text": "The role of different PI3K protein subtypes in the metastasis, angiogenesis and clinical prognosis of hepatocellular carcinoma."}, {"pubmed": 34603784, "text": "PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer."}, {"pubmed": 34990021, "text": "PIP3 abundance overcomes PI3K signaling selectivity in invadopodia."}, {"pubmed": 35225421, "text": "HMGB1/PTEN/PI3K axis participates in the peripheral immune cell differentiation in two representative TCM syndromes of chronic hepatitis B patients."}, {"pubmed": 35459184, "text": "CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells."}, {"pubmed": 36179694, "text": "PI3Kbeta-regulated beta-catenin mediates EZH2 removal from promoters controlling primed human ESC stemness and primitive streak gene expression."}, {"pubmed": 36197777, "text": "Suppression of PI3Kp110beta Reduces Cell Viability and Induces Apoptosis in Human Esophageal Cancer."}, {"pubmed": 37036671, "text": "AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)."}, {"pubmed": 37402056, "text": "Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma."}, {"pubmed": 38713746, "text": "Molecular dissection of PI3Kbeta synergistic activation by receptor tyrosine kinases, GbetaGgamma, and Rho-family GTPases."}, {"pubmed": 38757931, "text": "PI3K/HSCB axis facilitates FOG1 nuclear translocation to promote erythropoiesis and megakaryopoiesis."}], "genomic_pos": {"chr": "3", "end": 138834928, "ensemblgene": "ENSG00000051382", "start": 138652698, "strand": -1}, "genomic_pos_hg19": {"chr": "3", "end": 138553780, "start": 138372860, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001935", "qualifier": "involved_in", "term": "endothelial cell proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0001952", "pubmed": 25139353, "qualifier": "acts_upstream_of_or_within", "term": "regulation of cell-matrix adhesion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0002931", "pubmed": 30496354, "qualifier": "involved_in", "term": "response to ischemia"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0003376", "pubmed": 18558630, "qualifier": "involved_in", "term": "sphingosine-1-phosphate receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006874", "qualifier": "involved_in", "term": "intracellular calcium ion homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006897", "qualifier": "involved_in", "term": "endocytosis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006914", "qualifier": "involved_in", "term": "autophagy"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006935", "pubmed": 10570282, "qualifier": "involved_in", "term": "chemotaxis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007156", "qualifier": "involved_in", "term": "homophilic cell adhesion via plasma membrane adhesion molecules"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 10570282, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007169", "pubmed": 21035500, "qualifier": "involved_in", "term": "cell surface receptor protein tyrosine kinase signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007186", "pubmed": 21321382, "qualifier": "involved_in", "term": "G protein-coupled receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0010508", "pubmed": 21321382, "qualifier": "involved_in", "term": "positive regulation of autophagy"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0010595", "pubmed": 18558630, "qualifier": "involved_in", "term": "positive regulation of endothelial cell migration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010628", "pubmed": 25139353, "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of gene expression"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0016310", "pubmed": 25327288, "qualifier": "acts_upstream_of_or_within", "term": "phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0016477", "qualifier": "involved_in", "term": "cell migration"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0016477", "pubmed": [21035500, 21321382], "qualifier": "involved_in", "term": "cell migration"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0030168", "pubmed": 21035500, "qualifier": "involved_in", "term": "platelet activation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0033031", "pubmed": 25339672, "qualifier": "involved_in", "term": "positive regulation of neutrophil apoptotic process"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0035022", "pubmed": 18558630, "qualifier": "involved_in", "term": "positive regulation of Rac protein signal transduction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0036092", "qualifier": "involved_in", "term": "phosphatidylinositol-3-phosphate biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0040016", "qualifier": "involved_in", "term": "embryonic cleavage"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043409", "pubmed": 30496354, "qualifier": "involved_in", "term": "negative regulation of MAPK cascade"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043491", "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0043491", "pubmed": 30496354, "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043491", "pubmed": [18558630, 25339672], "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043491", "pubmed": 30496354, "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0043491", "pubmed": 21321382, "qualifier": "involved_in", "term": "phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045429", "pubmed": 18558630, "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of nitric oxide biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046854", "pubmed": 12502714, "qualifier": "involved_in", "term": "phosphatidylinositol phosphate biosynthetic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048015", "qualifier": "involved_in", "term": "phosphatidylinositol-mediated signaling"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0051898", "pubmed": 30496354, "qualifier": "involved_in", "term": "negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060055", "qualifier": "involved_in", "term": "angiogenesis involved in wound healing"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0070527", "pubmed": 21035500, "qualifier": "involved_in", "term": "platelet aggregation"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1900747", "pubmed": 30496354, "qualifier": "involved_in", "term": "negative regulation of vascular endothelial growth factor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1903298", "qualifier": "involved_in", "term": "negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1903671", "pubmed": 30496354, "qualifier": "involved_in", "term": "negative regulation of sprouting angiogenesis"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:2000369", "pubmed": 21321382, "qualifier": "involved_in", "term": "regulation of clathrin-dependent endocytosis"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 30496354, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005942", "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0005943", "pubmed": [20713702, 22402981], "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex, class IA"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005943", "pubmed": 20379207, "qualifier": "part_of", "term": "phosphatidylinositol 3-kinase complex, class IA"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030496", "qualifier": "located_in", "term": "midbody"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "located_in", "term": "intracellular membrane-bounded organelle"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [19380743, 20713702, 22402981, 25241761, 25556234, 25814554, 26496610, 27107012, 28514442, 32707033, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016301", "pubmed": 25327288, "qualifier": "enables", "term": "kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016303", "qualifier": "enables", "term": "1-phosphatidylinositol-3-kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0016303", "pubmed": 21035500, "qualifier": "enables", "term": "1-phosphatidylinositol-3-kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0035005", "qualifier": "enables", "term": "1-phosphatidylinositol-4-phosphate 3-kinase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0043560", "qualifier": "enables", "term": "insulin receptor substrate binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0046934", "pubmed": 12502714, "qualifier": "enables", "term": "1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0046934", "qualifier": "enables", "term": "1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0106310", "pubmed": 12502714, "qualifier": "enables", "term": "protein serine kinase activity"}]}, "homologene": {"genes": [[7955, 100002263], [8364, 780390], [9031, 424826], [9544, 716098], [9598, 471079], [9606, 5291], [9615, 477085], [9913, 517948], [10090, 74769], [10116, 85243]], "id": 21250}, "interpro": [{"desc": "Phosphatidylinositol 3-/4-kinase, catalytic domain", "id": "IPR000403", "short_desc": "PI3/4_kinase_cat_dom"}, {"desc": "Phosphoinositide 3-kinase, accessory (PIK) domain", "id": "IPR001263", "short_desc": "PI3K_accessory_dom"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Phosphatidylinositol kinase", "id": "IPR015433", "short_desc": "PI_Kinase"}, {"desc": "Armadillo-type fold", "id": "IPR016024", "short_desc": "ARM-type_fold"}, {"desc": "Phosphatidylinositol 3/4-kinase, conserved site", "id": "IPR018936", "short_desc": "PI3/4_kinase_CS"}, {"desc": "Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily", "id": "IPR036940", "short_desc": "PI3/4_kinase_cat_sf"}, {"desc": "PI3Kbeta, catalytic domain", "id": "IPR037702", "short_desc": "PI3Kbeta_dom"}, {"desc": "Phosphoinositide 3-kinase, accessory (PIK) domain superfamily", "id": "IPR042236", "short_desc": "PI3K_accessory_sf"}, {"desc": "Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain", "id": "IPR000341", "short_desc": "PI3K_Ras-bd_dom"}, {"desc": "C2 phosphatidylinositol 3-kinase-type domain", "id": "IPR002420", "short_desc": "PI3K-type_C2_dom"}, {"desc": "Phosphatidylinositol 3-kinase, adaptor-binding domain", "id": "IPR003113", "short_desc": "PI3K_ABD"}, {"desc": "Ubiquitin-like domain superfamily", "id": "IPR029071", "short_desc": "Ubiquitin-like_domsf"}, {"desc": "C2 domain superfamily", "id": "IPR035892", "short_desc": "C2_domain_sf"}, {"desc": "Phosphatidylinositol 3-kinase, Vps34 type", "id": "IPR008290", "short_desc": "PI3K_Vps34"}], "ipi": ["IPI00031388", "IPI00797179", "IPI00945232", "IPI00946458", "IPI00946617", "IPI00946800"], "map_location": "3q22.3", "name": "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta", "other_names": ["PI3-kinase p110 subunit beta", "PI3-kinase subunit beta", "PI3K-beta", "PtdIns-3-kinase p110", "phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta", "phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform", "phosphoinositide-3-kinase, catalytic, beta polypeptide", "ptdIns-3-kinase subunit beta", "ptdIns-3-kinase subunit p110-beta", "serine/threonine protein kinase PIK3CB"], "pantherdb": {"HGNC": "8976", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1922019", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 10090, "uniprot_kb": "Q8BTI9"}, {"RGD": "620917", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 10116, "uniprot_kb": "Q9Z1L0"}, {"Ensembl": "ENSGALG00000005505", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 9031, "uniprot_kb": "Q5F4A2"}, {"ZFIN": "ZDB-GENE-030131-1904", "ortholog_type": "LDO", "panther_family": "PTHR10048", "taxid": 7955, "uniprot_kb": "E7F251"}, {"FlyBase": "FBgn0015279", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 7227, "uniprot_kb": "P91634"}, {"dictyBase": "DDB_G0268548", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "Q55FX5"}, {"dictyBase": "DDB_G0283081", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "P54674"}, {"dictyBase": "DDB_G0282625", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "Q54S78"}, {"dictyBase": "DDB_G0275011", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "P54675"}, {"dictyBase": "DDB_G0278727", "ortholog_type": "O", "panther_family": "PTHR10048", "taxid": 352472, "uniprot_kb": "P54673"}], "uniprot_kb": "P42338"}, "pathway": {"humancyc": [{"id": "PWY-6352", "name": "3-phosphoinositide biosynthesis"}, {"id": "PWY-6371", "name": "superpathway of inositol phosphate compounds"}], "kegg": [{"id": "hsa00562", "name": "Inositol phosphate metabolism - Homo sapiens (human)"}, {"id": "hsa04012", "name": "ErbB signaling pathway - Homo sapiens (human)"}, {"id": "hsa04014", "name": "Ras signaling pathway - Homo sapiens (human)"}, {"id": "hsa04015", "name": "Rap1 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04024", "name": "cAMP signaling pathway - Homo sapiens (human)"}, {"id": "hsa04062", "name": "Chemokine signaling pathway - Homo sapiens (human)"}, {"id": "hsa04066", "name": "HIF-1 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04068", "name": "FoxO signaling pathway - Homo sapiens (human)"}, {"id": "hsa04070", "name": "Phosphatidylinositol signaling system - Homo sapiens (human)"}, {"id": "hsa04071", "name": "Sphingolipid signaling pathway - Homo sapiens (human)"}, {"id": "hsa04072", "name": "Phospholipase D signaling pathway - Homo sapiens (human)"}, {"id": "hsa04140", "name": "Autophagy - animal - Homo sapiens (human)"}, {"id": "hsa04150", "name": "mTOR signaling pathway - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04152", "name": "AMPK signaling pathway - Homo sapiens (human)"}, {"id": "hsa04210", "name": "Apoptosis - Homo sapiens (human)"}, {"id": "hsa04211", "name": "Longevity regulating pathway - Homo sapiens (human)"}, {"id": "hsa04213", "name": "Longevity regulating pathway - multiple species - Homo sapiens (human)"}, {"id": "hsa04218", "name": "Cellular senescence - Homo sapiens (human)"}, {"id": "hsa04360", "name": "Axon guidance - Homo sapiens (human)"}, {"id": "hsa04370", "name": "VEGF signaling pathway - Homo sapiens (human)"}, {"id": "hsa04380", "name": "Osteoclast differentiation - Homo sapiens (human)"}, {"id": "hsa04510", "name": "Focal adhesion - Homo sapiens (human)"}, {"id": "hsa04550", "name": "Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)"}, {"id": "hsa04611", "name": "Platelet activation - Homo sapiens (human)"}, {"id": "hsa04613", "name": "Neutrophil extracellular trap formation - Homo sapiens (human)"}, {"id": "hsa04620", "name": "Toll-like receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04625", "name": "C-type lectin receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)"}, {"id": "hsa04650", "name": "Natural killer cell mediated cytotoxicity - Homo sapiens (human)"}, {"id": "hsa04660", "name": "T cell receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04662", "name": "B cell receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04664", "name": "Fc epsilon RI signaling pathway - Homo sapiens (human)"}, {"id": "hsa04666", "name": "Fc gamma R-mediated phagocytosis - Homo sapiens (human)"}, {"id": "hsa04668", "name": "TNF signaling pathway - Homo sapiens (human)"}, {"id": "hsa04670", "name": "Leukocyte transendothelial migration - Homo sapiens (human)"}, {"id": "hsa04722", "name": "Neurotrophin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04725", "name": "Cholinergic synapse - Homo sapiens (human)"}, {"id": "hsa04750", "name": "Inflammatory mediator regulation of TRP channels - Homo sapiens (human)"}, {"id": "hsa04810", "name": "Regulation of actin cytoskeleton - Homo sapiens (human)"}, {"id": "hsa04910", "name": "Insulin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04914", "name": "Progesterone-mediated oocyte maturation - Homo sapiens (human)"}, {"id": "hsa04915", "name": "Estrogen signaling pathway - Homo sapiens (human)"}, {"id": "hsa04917", "name": "Prolactin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04919", "name": "Thyroid hormone signaling pathway - Homo sapiens (human)"}, {"id": "hsa04923", "name": "Regulation of lipolysis in adipocytes - Homo sapiens (human)"}, {"id": "hsa04926", "name": "Relaxin signaling pathway - Homo sapiens (human)"}, {"id": "hsa04929", "name": "GnRH secretion - Homo sapiens (human)"}, {"id": "hsa04930", "name": "Type II diabetes mellitus - Homo sapiens (human)"}, {"id": "hsa04931", "name": "Insulin resistance - Homo sapiens (human)"}, {"id": "hsa04932", "name": "Non-alcoholic fatty liver disease - Homo sapiens (human)"}, {"id": "hsa04933", "name": "AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human)"}, {"id": "hsa04935", "name": "Growth hormone synthesis, secretion and action - Homo sapiens (human)"}, {"id": "hsa04960", "name": "Aldosterone-regulated sodium reabsorption - Homo sapiens (human)"}, {"id": "hsa04973", "name": "Carbohydrate digestion and absorption - Homo sapiens (human)"}, {"id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)"}, {"id": "hsa05017", "name": "Spinocerebellar ataxia - Homo sapiens (human)"}, {"id": "hsa05020", "name": "Prion disease - Homo sapiens (human)"}, {"id": "hsa05100", "name": "Bacterial invasion of epithelial cells - Homo sapiens (human)"}, {"id": "hsa05131", "name": "Shigellosis - Homo sapiens (human)"}, {"id": "hsa05132", "name": "Salmonella infection - Homo sapiens (human)"}, {"id": "hsa05135", "name": "Yersinia infection - Homo sapiens (human)"}, {"id": "hsa05142", "name": "Chagas disease - Homo sapiens (human)"}, {"id": "hsa05146", "name": "Amoebiasis - Homo sapiens (human)"}, {"id": "hsa05160", "name": "Hepatitis C - Homo sapiens (human)"}, {"id": "hsa05161", "name": "Hepatitis B - Homo sapiens (human)"}, {"id": "hsa05162", "name": "Measles - Homo sapiens (human)"}, {"id": "hsa05163", "name": "Human cytomegalovirus infection - Homo sapiens (human)"}, {"id": "hsa05164", "name": "Influenza A - Homo sapiens (human)"}, {"id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)"}, {"id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05167", "name": "Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)"}, {"id": "hsa05168", "name": "Herpes simplex virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05170", "name": "Human immunodeficiency virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05203", "name": "Viral carcinogenesis - Homo sapiens (human)"}, {"id": "hsa05205", "name": "Proteoglycans in cancer - Homo sapiens (human)"}, {"id": "hsa05206", "name": "MicroRNAs in cancer - Homo sapiens (human)"}, {"id": "hsa05210", "name": "Colorectal cancer - Homo sapiens (human)"}, {"id": "hsa05211", "name": "Renal cell carcinoma - Homo sapiens (human)"}, {"id": "hsa05212", "name": "Pancreatic cancer - Homo sapiens (human)"}, {"id": "hsa05213", "name": "Endometrial cancer - Homo sapiens (human)"}, {"id": "hsa05214", "name": "Glioma - Homo sapiens (human)"}, {"id": "hsa05215", "name": "Prostate cancer - Homo sapiens (human)"}, {"id": "hsa05218", "name": "Melanoma - Homo sapiens (human)"}, {"id": "hsa05220", "name": "Chronic myeloid leukemia - Homo sapiens (human)"}, {"id": "hsa05221", "name": "Acute myeloid leukemia - Homo sapiens (human)"}, {"id": "hsa05222", "name": "Small cell lung cancer - Homo sapiens (human)"}, {"id": "hsa05223", "name": "Non-small cell lung cancer - Homo sapiens (human)"}, {"id": "hsa05224", "name": "Breast cancer - Homo sapiens (human)"}, {"id": "hsa05225", "name": "Hepatocellular carcinoma - Homo sapiens (human)"}, {"id": "hsa05226", "name": "Gastric cancer - Homo sapiens (human)"}, {"id": "hsa05230", "name": "Central carbon metabolism in cancer - Homo sapiens (human)"}, {"id": "hsa05231", "name": "Choline metabolism in cancer - Homo sapiens (human)"}, {"id": "hsa05235", "name": "PD-L1 expression and PD-1 checkpoint pathway in cancer - Homo sapiens (human)"}, {"id": "hsa05415", "name": "Diabetic cardiomyopathy - Homo sapiens (human)"}, {"id": "hsa05417", "name": "Lipid and atherosclerosis - Homo sapiens (human)"}, {"id": "hsa05418", "name": "Fluid shear stress and atherosclerosis - Homo sapiens (human)"}], "netpath": [{"id": "Pathway_Alpha6Beta4Integrin", "name": "Alpha6Beta4Integrin"}, {"id": "Pathway_EGFR1", "name": "EGFR1"}, {"id": "Pathway_IL2", "name": "IL2"}], "pid": [{"id": "cd40_pathway", "name": "CD40/CD40L signaling"}, {"id": "cxcr3pathway", "name": "CXCR3-mediated signaling events"}, {"id": "cxcr4_pathway", "name": "CXCR4-mediated signaling events"}, {"id": "erbb1_downstream_pathway", "name": "ErbB1 downstream signaling"}, {"id": "erbb1_internalization_pathway", "name": "Internalization of ErbB1"}, {"id": "erbb2erbb3pathway", "name": "ErbB2/ErbB3 signaling events"}, {"id": "erbb4_pathway", "name": "ErbB4 signaling events"}, {"id": "faspathway", "name": "FAS (CD95) signaling pathway"}, {"id": "lysophospholipid_pathway", "name": "LPA receptor mediated events"}, {"id": "nephrin_neph1_pathway", "name": "Nephrin/Neph1 signaling in the kidney podocyte"}, {"id": "pdgfrbpathway", "name": "PDGFR-beta signaling pathway"}, {"id": "pi3kcipathway", "name": "Class I PI3K signaling events"}, {"id": "tcptp_pathway", "name": "Signaling events mediated by TCPTP"}, {"id": "trail_pathway", "name": "TRAIL signaling pathway"}], "reactome": [{"id": "R-HSA-109582", "name": "Hemostasis"}, {"id": "R-HSA-109704", "name": "PI3K Cascade"}, {"id": "R-HSA-112399", "name": "IRS-mediated signalling"}, {"id": "R-HSA-114604", "name": "GPVI-mediated activation cascade"}, {"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1483255", "name": "PI Metabolism"}, {"id": "R-HSA-1483257", "name": "Phospholipid metabolism"}, {"id": "R-HSA-1500931", "name": "Cell-Cell communication"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-1660499", "name": "Synthesis of PIPs at the plasma membrane"}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-186763", "name": "Downstream signal transduction"}, {"id": "R-HSA-186797", "name": "Signaling by PDGF"}, {"id": "R-HSA-187037", "name": "Signaling by NTRK1 (TRKA)"}, {"id": "R-HSA-194138", "name": "Signaling by VEGF"}, {"id": "R-HSA-194138", "name": "Signaling by VEGF"}, {"id": "R-HSA-198203", "name": "PI3K/AKT activation"}, {"id": "R-HSA-199418", "name": "Negative regulation of the PI3K/AKT network"}, {"id": "R-HSA-201556", "name": "Signaling by ALK"}, {"id": "R-HSA-202403", "name": "TCR signaling"}, {"id": "R-HSA-202424", "name": "Downstream TCR signaling"}, {"id": "R-HSA-202733", "name": "Cell surface interactions at the vascular wall"}, {"id": "R-HSA-2029480", "name": "Fcgamma receptor (FCGR) dependent phagocytosis"}, {"id": "R-HSA-2029485", "name": "Role of phospholipids in phagocytosis"}, {"id": "R-HSA-210993", "name": "Tie2 Signaling"}, {"id": "R-HSA-2172127", "name": "DAP12 interactions"}, {"id": "R-HSA-2219528", "name": "PI3K/AKT Signaling in Cancer"}, {"id": "R-HSA-2219530", "name": "Constitutive Signaling by Aberrant PI3K in Cancer"}, {"id": "R-HSA-2404192", "name": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"}, {"id": "R-HSA-2424491", "name": "DAP12 signaling"}, {"id": "R-HSA-2428924", "name": "IGF1R signaling cascade"}, {"id": "R-HSA-2428928", "name": "IRS-related events triggered by IGF1R"}, {"id": "R-HSA-2454202", "name": "Fc epsilon receptor (FCERI) signaling"}, {"id": "R-HSA-2730905", "name": "Role of LAT2/NTAL/LAB on calcium mobilization"}, {"id": "R-HSA-373753", "name": "Nephrin family interactions"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-4420097", "name": "VEGFA-VEGFR2 Pathway"}, {"id": "R-HSA-4420097", "name": "VEGFA-VEGFR2 Pathway"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-451927", "name": "Interleukin-2 family signaling"}, {"id": "R-HSA-512988", "name": "Interleukin-3, Interleukin-5 and GM-CSF signaling"}, {"id": "R-HSA-512988", "name": "Interleukin-3, Interleukin-5 and GM-CSF signaling"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6811558", "name": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"}, {"id": "R-HSA-74751", "name": "Insulin receptor signalling cascade"}, {"id": "R-HSA-74752", "name": "Signaling by Insulin receptor"}, {"id": "R-HSA-76002", "name": "Platelet activation, signaling and aggregation"}, {"id": "R-HSA-8853659", "name": "RET signaling"}, {"id": "R-HSA-9006335", "name": "Signaling by Erythropoietin"}, {"id": "R-HSA-9006335", "name": "Signaling by Erythropoietin"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9027276", "name": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"}, {"id": "R-HSA-9027276", "name": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)"}, {"id": "R-HSA-912526", "name": "Interleukin receptor SHC signaling"}, {"id": "R-HSA-912631", "name": "Regulation of signaling by CBL"}, {"id": "R-HSA-912631", "name": "Regulation of signaling by CBL"}, {"id": "R-HSA-9671555", "name": "Signaling by PDGFR in disease"}, {"id": "R-HSA-9673767", "name": "Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants"}, {"id": "R-HSA-9673770", "name": "Signaling by PDGFRA extracellular domain mutants"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9680350", "name": "Signaling by CSF1 (M-CSF) in myeloid cells"}, {"id": "R-HSA-9700206", "name": "Signaling by ALK in cancer"}, {"id": "R-HSA-9725370", "name": "Signaling by ALK fusions and activated point mutants"}, {"id": "R-HSA-9842640", "name": "Signaling by LTK in cancer"}, {"id": "R-HSA-9842663", "name": "Signaling by LTK"}], "wikipathways": [{"id": "WP1403", "name": "AMP-activated protein kinase (AMPK) signaling"}, {"id": "WP1449", "name": "Regulation of toll-like receptor signaling pathway"}, {"id": "WP1544", "name": "MicroRNAs in cardiomyocyte hypertrophy"}, {"id": "WP2037", "name": "Prolactin Signaling Pathway"}, {"id": "WP2261", "name": "Glioblastoma signaling pathways"}, {"id": "WP306", "name": "Focal Adhesion"}, {"id": "WP3844", "name": "PI3K-AKT-mTOR signaling pathway and therapeutic opportunities"}, {"id": "WP3915", "name": "Angiopoietin Like Protein 8 Regulatory Pathway"}, {"id": "WP3929", "name": "Chemokine signaling pathway"}, {"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP3937", "name": "Microglia Pathogen Phagocytosis Pathway"}, {"id": "WP4155", "name": "Endometrial cancer"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4217", "name": "Ebola Virus Pathway on Host"}, {"id": "WP4223", "name": "Ras signaling"}, {"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4255", "name": "Non-small cell lung cancer"}, {"id": "WP4263", "name": "Pancreatic adenocarcinoma pathway"}, {"id": "WP4396", "name": "Nonalcoholic fatty liver disease"}, {"id": "WP4481", "name": "Resistin as a regulator of inflammation"}, {"id": "WP4483", "name": "Relationship between inflammation, COX-2 and EGFR"}, {"id": "WP4539", "name": "Synaptic signaling pathways associated with autism spectrum disorder"}, {"id": "WP4549", "name": "Fragile X Syndrome"}, {"id": "WP4564", "name": "Neural Crest Cell Migration during Development"}, {"id": "WP4565", "name": "Neural Crest Cell Migration in Cancer"}, {"id": "WP4566", "name": "Translation inhibitors in chronically activated PDGFRA cells"}, {"id": "WP4582", "name": "Cancer immunotherapy by CTLA4 blockade"}, {"id": "WP4658", "name": "Small cell lung cancer"}, {"id": "WP4666", "name": "Hepatitis B infection"}, {"id": "WP4674", "name": "Head and Neck Squamous Cell Carcinoma"}, {"id": "WP4685", "name": "Melanoma"}, {"id": "WP4787", "name": "Osteoblast differentiation"}, {"id": "WP4806", "name": "EGFR Tyrosine Kinase Inhibitor Resistance"}, {"id": "WP481", "name": "Insulin Signaling"}, {"id": "WP4829", "name": "mBDNF and proBDNF regulation of GABA neurotransmission"}, {"id": "WP4871", "name": "Kisspeptin-kisspeptin receptor system in the ovary"}, {"id": "WP51", "name": "Regulation of Actin Cytoskeleton"}, {"id": "WP524", "name": "G13 Signaling Pathway"}, {"id": "WP673", "name": "ErbB signaling pathway"}, {"id": "WP710", "name": "DNA damage response (only ATM dependent)"}, {"id": "WP75", "name": "Toll-like Receptor Signaling Pathway"}]}, "pfam": ["PF00454", "PF00613", "PF00792", "PF00794", "PF02192"], "pharmgkb": "PA33309", "pharos": {"target_id": 17815, "tdl": "Tchem"}, "pir": "A54600", "prosite": ["PS50290", "PS51544", "PS51545", "PS51546", "PS51547"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF254183", "relationship": "is"}, {"id": "GNF254184", "relationship": "is"}, {"id": "GNF254185", "relationship": "is"}, {"id": "GNF254186", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF046751", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087424", "relationship": "is"}, {"id": "GNF087425", "relationship": "is"}, {"id": "GNF087426", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050867", "relationship": "is"}, {"id": "GNF055630", "relationship": "is"}, {"id": "GNF060299", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069289", "relationship": "is"}, {"id": "GNF069290", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF276022", "relationship": "is"}, "Invitrogen_IVTHSSIPKv2": [{"id": "GNF324740", "relationship": "is"}, {"id": "GNF324741", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF339123", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094619", "relationship": "is"}, {"id": "GNF134276", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1"], "protein": ["NP_001242974.1", "NP_006210.1", "XP_006713722.1", "XP_011511197.1", "XP_016862108.1", "XP_047304263.1", "XP_047304264.1", "XP_047304265.1", "XP_047304266.1", "XP_047304267.1", "XP_047304268.1", "XP_047304269.1", "XP_047304270.1", "XP_047304271.1", "XP_054202824.1", "XP_054202825.1", "XP_054202826.1", "XP_054202827.1", "XP_054202828.1", "XP_054202829.1", "XP_054202830.1", "XP_054202831.1", "XP_054202832.1", "XP_054202833.1"], "rna": ["NM_001256045.2", "NM_006219.3", "XM_006713659.4", "XM_011512895.3", "XM_017006619.2", "XM_047448307.1", "XM_047448308.1", "XM_047448309.1", "XM_047448310.1", "XM_047448311.1", "XM_047448312.1", "XM_047448313.1", "XM_047448314.1", "XM_047448315.1", "XM_054346849.1", "XM_054346850.1", "XM_054346851.1", "XM_054346852.1", "XM_054346853.1", "XM_054346854.1", "XM_054346855.1", "XM_054346856.1", "XM_054346857.1", "XM_054346858.1"], "translation": [{"protein": "XP_006713722.1", "rna": "XM_006713659.4"}, {"protein": "XP_047304264.1", "rna": "XM_047448308.1"}, {"protein": "XP_054202833.1", "rna": "XM_054346858.1"}, {"protein": "XP_054202832.1", "rna": "XM_054346857.1"}, {"protein": "XP_047304271.1", "rna": "XM_047448315.1"}, {"protein": "NP_006210.1", "rna": "NM_006219.3"}, {"protein": "XP_054202825.1", "rna": "XM_054346850.1"}, {"protein": "XP_054202831.1", "rna": "XM_054346856.1"}, {"protein": "NP_001242974.1", "rna": "NM_001256045.2"}, {"protein": "XP_054202830.1", "rna": "XM_054346855.1"}, {"protein": "XP_047304263.1", "rna": "XM_047448307.1"}, {"protein": "XP_047304266.1", "rna": "XM_047448310.1"}, {"protein": "XP_047304267.1", "rna": "XM_047448311.1"}, {"protein": "XP_047304270.1", "rna": "XM_047448314.1"}, {"protein": "XP_054202827.1", "rna": "XM_054346852.1"}, {"protein": "XP_054202824.1", "rna": "XM_054346849.1"}, {"protein": "XP_054202828.1", "rna": "XM_054346853.1"}, {"protein": "XP_047304268.1", "rna": "XM_047448312.1"}, {"protein": "XP_054202826.1", "rna": "XM_054346851.1"}, {"protein": "XP_011511197.1", "rna": "XM_011512895.3"}, {"protein": "XP_047304269.1", "rna": "XM_047448313.1"}, {"protein": "XP_047304265.1", "rna": "XM_047448309.1"}, {"protein": "XP_054202829.1", "rna": "XM_054346854.1"}, {"protein": "XP_016862108.1", "rna": "XM_017006619.2"}]}, "reporter": {"HG-U133_Plus_2": ["212688_at", "217620_s_at"], "HG-U95Av2": ["1163_at", "31699_at"], "HG-U95B": "51223_at", "HTA-2_0": "TC03001824.hg.1", "HuEx-1_0": ["2697562", "2697564"], "HuGene-1_1": "8091009", "HuGene-2_1": "16959701"}, "summary": "This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K). These kinases are important in signaling pathways involving receptors on the outer membrane of eukaryotic cells and are named for their catalytic subunit. The encoded protein is the catalytic subunit for PI3Kbeta (PI3KB). PI3KB has been shown to be part of the activation pathway in neutrophils which have bound immune complexes at sites of injury or infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011].", "symbol": "PIK3CB", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1335213"}, "unigene": "Hs.239818", "uniprot": {"Swiss-Prot": "P42338", "TrEMBL": ["Q68DL0", "B4DER4", "F8WDJ8", "C9JYX0", "C9J345", "H7C565", "H7C5C3", "H7C527", "H0Y871"]}, "wikipedia": {"url_stub": "PIK3CB"}}